

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III ...
Q2 2026
Aug 14, 2026
Q1 2026
May 19, 2026
FY 2025
Mar 26, 2026
Q4 2025
Mar 26, 2026
Q3 2025
Nov 13, 2025